Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Trevi Therapeutics Inc (NQ: TRVI )

2.970 -0.100 (-3.26%)
Streaming Delayed Price Updated: 2:23 PM EST, Nov 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Trevi Therapeutics Inc

< Previous 1 2 3 4 Next >
Why Trevi Therapeutics Could Be a Triple-Bagger Biotech Stock
Wall Street analysts see big potential upside for small-cap biopharma firm Trevi Therapeutics. So, what does the firm do and how does it stand out? 
Via MarketBeat
Exposures Product Safety
TRVI Stock Earnings: Trevi Therapeutics Misses EPS for Q2 2024
TRVI stock results show that Trevi Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
TRVI Stock Earnings: Trevi Therapeutics Misses EPS for Q1 2024
TRVI stock results show that Trevi Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
TRVI Stock Earnings: Trevi Therapeutics Beats EPS for Q4 2023
TRVI stock results show that Trevi Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Trevi Therapeutics: Q4 Earnings Insights
Via Benzinga
Earnings Outlook For Trevi Therapeutics
Via Benzinga
Trevi Therapeutics's Earnings: A Preview
Via Benzinga
Recap: Trevi Therapeutics Q1 Earnings
Via Benzinga
Earnings Scheduled For March 20, 2024
Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Earnings Outlook For Trevi Therapeutics
Via Benzinga
Trevi Therapeutics Shares Jump After Complete Data From Chronic Cough Trial
Via Benzinga
Earnings Scheduled For November 9, 2023
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
Earnings Preview: Trevi Therapeutics
Via Benzinga
Earnings Scheduled For May 11, 2023
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its... 
Via Benzinga
Earnings Scheduled For March 16, 2023
Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly earnings at $0.03 per share on revenue of $34.29 million. 
Via Benzinga
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
Via Benzinga
Trevi Therapeutics, Inc. Discusses Progress and 2022 Success of Clinical Studies for Its Investigational Oral Therapy Haduvio(TM) with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - January 25, 2023) - The Stock Day Podcast welcomed Trevi Therapeutics, Inc. (NASDAQ: TRVI) ("the Company"),... 
Via Newsfile
Why Manchester United Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 58.4% to $0.1069 in pre-market trading after gaining more than 16% on Tuesday. 
Via Benzinga
Earnings Scheduled For November 10, 2022
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter. 
Via Benzinga
Earnings Outlook For Trevi Therapeutics, Inc. - Common Stock
Trevi Therapeutics, Inc. - Common Stock (NASDAQ:TRVI) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement. 
Via Benzinga
Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
  
Via Benzinga
Trevi Therapeutics, Inc. Discusses Commercialization for Its Investigational Therapy, Haduvio, with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - August 22, 2022) - The Stock Day Podcast welcomed Trevi Therapeutics, Inc. (NASDAQ: TRVI) ("the Company"),... 
Via Newsfile
Exposures Product Safety
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.